The anti-tumor effect of LRP5-overexpressing osteocyte-derived CM was attenuated upon MYO5B knockdown, and functional rescue experiments further confirmed that the integrity of the LIMA1-MYO5B axis is essential for the anti-tumor activity of LRP5-overexpressing osteocyte-derived CM. This evidence concerns the gene LIMA1 and neoplasm.